Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria

article

Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1107253008
P356DOI10.1186/S12885-018-4821-8
P2888exact matchhttps://scigraph.springernature.com/pub.10.1186/s12885-018-4821-8
P932PMC publication ID6158817
P698PubMed publication ID30257646

P50authorAndré ReisQ522465
Georgia VasileiouQ59942909
Peter A. FaschingQ64005064
Matthias W. BeckmannQ72940290
Arndt HartmannQ89782316
Michael P. LuxQ37372079
P2093author name stringCornelia Kraus
Steffen Uebe
Christian T Thiel
Juliane Hoyer
Marius Wunderle
P2860cites workPALB2 is an integral component of the BRCA complex required for homologous recombination repairQ24316113
Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methodsQ25255759
Analysis of protein-coding genetic variation in 60,706 humansQ26831376
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriersQ27851474
A method and server for predicting damaging missense mutationsQ27860835
Triple-Negative Breast CancerQ29391607
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmQ29547194
"An addendum to breast cancer": the triple negative experienceQ30277052
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.Q30432372
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.Q31120259
A novel germline PALB2 deletion in Polish breast and ovarian cancer patientsQ33528298
Epidemiology of contralateral breast cancerQ33766634
Frequency of BRCA1 mutation 5382insC in German breast cancer patients.Q33853807
Breast cancer susceptibility: current knowledge and implications for genetic counsellingQ34161642
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testingQ34228853
Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancerQ34460831
MutationTaster2: mutation prediction for the deep-sequencing age.Q52877992
Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.Q54650919
[Possibilities of examination of familial breast cancers and ovarian cancers. Use of molecular-genetic analysis of the BRCA1 gene and the BRCA2 gene]Q71845390
[Germ-line mutations of the BRCA1 gene in northeastern France]Q73205554
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German populationQ77523705
Immunophenotypic predictive profiling of BRCA1-associated breast cancerQ34467646
Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence informationQ34609519
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective studyQ34749278
Human Splicing Finder: an online bioinformatics tool to predict splicing signalsQ34973311
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerQ34996647
Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast CancersQ35665705
DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predispositionQ35993095
Founder mutations in BRCA1 and BRCA2 genesQ36860233
Clinical practice. Management of an inherited predisposition to breast cancerQ36877519
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutralQ36927199
Genetic predisposition to breast cancer: past, present, and futureQ37187786
UMD-Predictor: A High-Throughput Sequencing Compliant System for Pathogenicity Prediction of any Human cDNA SubstitutionQ37345605
PALB2 links BRCA1 and BRCA2 in the DNA-damage responseQ37361223
The negative effect of triple-negative breast cancer on outcome after breast-conserving therapyQ37858457
The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysisQ38109943
Toward better understanding of artifacts in variant calling from high-coverage samplesQ38224122
Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic ResultsQ38812876
Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.Q41740523
Germline E-cadherin mutations in familial lobular breast cancerQ42566631
Population genetics of BRCA1 and BRCA2.Q43109039
Functional variants in NBS1 and cancer risk: evidence from a meta-analysis of 60 publications with 111 individual studiesQ43841469
The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotypeQ46041916
Improved splice site detection in GenieQ46338894
Prediction of human mRNA donor and acceptor sites from the DNA sequenceQ48219047
Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.Q50301520
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectcancer researchQ3421914
P304page(s)926
P577publication date2018-09-26
P1433published inBMC CancerQ326300
P1476titleAddition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria
P478volume18

Reverse relations

cites work (P2860)
Q98163397Breast MRI texture analysis for prediction of BRCA-associated genetic risk
Q64102998Update Breast Cancer 2019 Part 1 - Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer
Q64102991Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice
Q89488563[Breast cancer in young women. Histological and prognostic specificities: how are they different from older women?]

Search more.